Literature DB >> 29321368

VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.

Julie Lacombe1, Mark A Rishavy2, Kathleen L Berkner2, Mathieu Ferron1,3,4.   

Abstract

Vertebrates possess 2 proteins with vitamin K oxidoreductase (VKOR) activity: VKORC1, whose vitamin K reduction supports vitamin K-dependent (VKD) protein carboxylation, and VKORC1-like 1 (VKORC1L1), whose function is unknown. VKD proteins include liver-derived coagulation factors, and hemorrhaging and lethality were previously observed in mice lacking either VKORC1 or the γ-glutamyl carboxylase (GGCX) that modifies VKD proteins. Vkorc1-/- mice survived longer (1 week) than Ggcx-/- mice (midembryogenesis or birth), and we assessed whether VKORC1L1 could account for this difference. We found that Vkorc1-/-;Vkorc1l1-/- mice died at birth with severe hemorrhaging, indicating that VKORC1L1 supports carboxylation during the pre- and perinatal periods. Additional studies showed that only VKORC1 sustains hemostasis beyond P7. VKORC1 expression and VKOR activity increased during late embryogenesis and following birth, while VKORC1L1 expression was unchanged. At P0, most (>99%) VKOR activity was due to VKORC1. Prothrombin mRNA, protein, and carboxylation also increased during this period, as did mRNA levels of coagulation factors encoding genes F7, F9, and F10. VKORC1L1 levels in Vkorc1-/- mouse liver may therefore be insufficient for supporting carboxylation beyond day 7. In support of this conclusion, VKORC1L1 overexpression in liver rescued carboxylation and hemostasis in adult Vkorc1-/- mice. These findings establish that VKORC1L1 supports VKD protein carboxylation in vivo.

Entities:  

Keywords:  Coagulation; Development; Hematology; Mouse models; Thrombin

Mesh:

Substances:

Year:  2018        PMID: 29321368      PMCID: PMC5821188          DOI: 10.1172/jci.insight.96501

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  23 in total

1.  Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.

Authors:  M Dewerchin; Z Liang; L Moons; P Carmeliet; F J Castellino; D Collen; E D Rosen
Journal:  Thromb Haemost       Date:  2000-02       Impact factor: 5.249

2.  Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.

Authors:  Michael Caspers; Katrin J Czogalla; Kerstin Liphardt; Jens Müller; Philipp Westhofen; Matthias Watzka; Johannes Oldenburg
Journal:  Thromb Res       Date:  2015-01-26       Impact factor: 3.944

3.  Plasma vitamin K1 in mothers and their newborn babies.

Authors:  M J Shearer; S Rahim; P Barkhan; L Stimmler
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

4.  Structure of a bacterial homologue of vitamin K epoxide reductase.

Authors:  Weikai Li; Sol Schulman; Rachel J Dutton; Dana Boyd; Jon Beckwith; Tom A Rapoport
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

5.  VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding.

Authors:  Gabriele Spohn; Andre Kleinridders; F Thomas Wunderlich; Matthias Watzka; Frank Zaucke; Katrin Blumbach; Christof Geisen; Erhard Seifried; Clemens Müller; Mats Paulsson; Jens C Brüning; Johannes Oldenburg
Journal:  Thromb Haemost       Date:  2009-06       Impact factor: 5.249

6.  Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster.

Authors:  C M Allan; S Taylor; J M Taylor
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

7.  Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.

Authors:  Simone Rost; Andreas Fregin; Vytautas Ivaskevicius; Ernst Conzelmann; Konstanze Hörtnagel; Hans-Joachim Pelz; Knut Lappegard; Erhard Seifried; Inge Scharrer; Edward G D Tuddenham; Clemens R Müller; Tim M Strom; Johannes Oldenburg
Journal:  Nature       Date:  2004-02-05       Impact factor: 49.962

8.  The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation.

Authors:  Mark A Rishavy; Kevin W Hallgren; Lee A Wilson; Aisulu Usubalieva; Kurt W Runge; Kathleen L Berkner
Journal:  J Biol Chem       Date:  2013-08-05       Impact factor: 5.157

9.  Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.

Authors:  Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

10.  Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.

Authors:  J Xue; Q Wu; L A Westfield; E A Tuley; D Lu; Q Zhang; K Shim; X Zheng; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  10 in total

1.  Warfarin, a juggler's demise.

Authors:  Laurent O Mosnier
Journal:  Blood       Date:  2018-06-21       Impact factor: 22.113

Review 2.  Vitamin K in CKD Bone Disorders.

Authors:  M Fusaro; G Cianciolo; P Evenepoel; L Schurgers; M Plebani
Journal:  Calcif Tissue Int       Date:  2021-01-06       Impact factor: 4.333

3.  Characterization of Warfarin Inhibition Kinetics Requires Stabilization of Intramembrane Vitamin K Epoxide Reductases.

Authors:  Shuang Li; Shixuan Liu; Yihu Yang; Weikai Li
Journal:  J Mol Biol       Date:  2020-05-20       Impact factor: 5.469

4.  Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and β-cell function.

Authors:  Julie Lacombe; Omar Al Rifai; Lorraine Loter; Thomas Moran; Anne-Frédérique Turcotte; Thomas Grenier-Larouche; André Tchernof; Laurent Biertho; André C Carpentier; Denis Prud'homme; Rémi Rabasa-Lhoret; Gerard Karsenty; Claudia Gagnon; Weiping Jiang; Mathieu Ferron
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-01-14       Impact factor: 4.310

5.  Exon 2 skipping eliminates γ-glutamyl carboxylase activity, indicating a partial splicing defect in a patient with vitamin K clotting factor deficiency.

Authors:  Mark A Rishavy; Kevin W Hallgren; Haitao Zhang; Kurt W Runge; Kathleen L Berkner
Journal:  J Thromb Haemost       Date:  2019-06-07       Impact factor: 5.824

6.  Targeting multiple enzymes in vitamin K metabolism for anticoagulation.

Authors:  Weikai Li
Journal:  J Thromb Haemost       Date:  2021-03       Impact factor: 5.824

7.  New Insights on Vitamin K Metabolism in Senegalese sole (Solea senegalensis) Based on Ontogenetic and Tissue-Specific Vitamin K Epoxide Reductase Molecular Data.

Authors:  Silvia Beato; Carlos Marques; Vincent Laizé; Paulo J Gavaia; Ignacio Fernández
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 8.  VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.

Authors:  Julie Lacombe; Mathieu Ferron
Journal:  Nutrients       Date:  2018-07-26       Impact factor: 5.717

9.  Pan-methylarginine antibody generation using PEG linked GAR motifs as antigens.

Authors:  Yalong Wang; Maria D Person; Mark T Bedford
Journal:  Methods       Date:  2021-06-06       Impact factor: 3.608

Review 10.  Vitamin K in Vertebrates' Reproduction: Further Puzzling Pieces of Evidence from Teleost Fish Species.

Authors:  Silvia Beato; Francisco Javier Toledo-Solís; Ignacio Fernández
Journal:  Biomolecules       Date:  2020-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.